YOSEMITE and RHINE: 2-year results of faricimab in diabetic macular edema indicate reduced treatment burden
May 04, 2022
Jennifer I. Lim, MD, FARVO, FASRS, reviews the 2-year results of the YOSEMITE and RHINE trials, outlining the efficacy, durability, and safety of faricimab in diabetic macular edema.